Atlas Trials

Aspeya, Inc.

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Aspeya, Inc.

RecordFirmDate
Phase 1 Study Evaluating Safety and Pharmacokinetics of ASY202 in Adults With Asthma (NCT07665892)Aspeya, Inc.2026-05-26
Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients (NCT07646613)Aspeya, Inc.2026-05-19

Track Aspeya, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.